Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Raul Rincon

3PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

|Jun 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Federico Rojo, Clive R Taylor, Carlos Barrios

|Apr 28, 2019
UNR/<i>CSDE1</i> Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.

Javier Martinez-Useros, Nuria Garcia-Carbonero, Weiyao Li

Pageof 1

Frequent Collaborators

2 joint publications

Federico Rojo

2 joint publications

Miguel Martín

2 joint publications

Manuel Ruiz-Borrego

2 joint publications

Angel Guerrero-Zotano

2 joint publications

Rosalía Caballero

2 joint publications

Jesus Herranz

1 joint publications

Javier Martinez-Useros

1 joint publications

Clive R Taylor

1 joint publications

Laura Torrecillas

1 joint publications

Sandra Perez-Buira

Frequent Collaborators

2 joint publications

Federico Rojo

2 joint publications

Miguel Martín

2 joint publications

Manuel Ruiz-Borrego

2 joint publications

Angel Guerrero-Zotano